Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:50 UTC |
---|
HMDB ID | HMDB0015031 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Testolactone |
---|
Description | Testolactone, also known as teslac, belongs to the class of organic compounds known as naphthopyrans. Naphthopyrans are compounds containing a pyran ring fused to a naphthalene moiety. Furan is a 6 membered-ring non-aromatic ring with five carbon and one oxygen atoms. Naphthalene is a polycyclic aromatic hydrocarbon made up of two fused benzene rings. Thus, testolactone is considered to be a steroid lipid molecule. Testolactone is a drug which is used for palliative treatment of advanced breast cancer in postmenopausal women. It works by blocking the production of estrogens, which helps prevent the growth of breast cancers that are stimulated by estrogens. Testolactone was first approved for medical use in the United States in 1970. Testolactone is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Androstenedione, a 19-carbon steroid hormone produced in the adrenal glands and the gonads, is where estrone synthesis originates and is the source of estrogen in postmenopausal women. In vitro studies report that the aromatase inhibition may be noncompetitive and irreversible, and could possibly account for the persistence of this drug's effect on estrogen synthesis after drug withdrawal. However, it has been reported to still be marketed in the United States by Bristol-Myers Squibb under the brand name Teslac. Testolactone has also been used to postpone precocious puberty because of its ability to block estrogen production. In addition to its activity as an aromatase inhibitor, testolactone also reportedly possesses some anabolic activity and weak androgenic activity via binding to and activation of the androgen receptor (AR). Testolactone (INN, USAN) (brand name Teslac) is a non-selective, irreversible, steroidal aromatase inhibitor which is used as an antineoplastic drug to treat advanced-stage breast cancer. |
---|
Structure | [H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H] InChI=1S/C19H24O3/c1-18-9-7-13(20)11-12(18)3-4-14-15(18)8-10-19(2)16(14)5-6-17(21)22-19/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15+,16+,18+,19+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(4AS,4BR,10ar,10BS,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4BH)-dione | ChEBI | 1,2-Didehydrotestololactone | ChEBI | 1-Dehydrotestololactone | ChEBI | 13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone | ChEBI | D-homo-17a-Oxaandrosta-1,4-diene-3,17-dione | ChEBI | delta(1)-Testololactone | ChEBI | Teslac | ChEBI | 13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oate delta-lactone | Generator | 13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oate Δ-lactone | Generator | 13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid Δ-lactone | Generator | Δ(1)-testololactone | Generator | 1-Dehydrotestolactone | MeSH, HMDB | 1 Dehydrotestolactone | MeSH, HMDB | delta(1)-Testolactone | MeSH, HMDB | 1,2-Dehydrotestololactone | HMDB | Testolactone | HMDB | delta1-Dehydrotestololactone | HMDB | delta1-Testolactone | HMDB | delta1-Testololactone | HMDB | Δ1-Dehydrotestololactone | HMDB | Δ1-Testolactone | HMDB | Δ1-Testololactone | HMDB |
| Show more...
---|
Chemical Formula | C19H24O3 |
---|
Average Molecular Weight | 300.3921 |
---|
Monoisotopic Molecular Weight | 300.172544634 |
---|
IUPAC Name | (1R,2S,7S,10S,11R)-7,11-dimethyl-6-oxatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-12,15-diene-5,14-dione |
---|
Traditional Name | (1R,2S,7S,10S,11R)-7,11-dimethyl-6-oxatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadeca-12,15-diene-5,14-dione |
---|
CAS Registry Number | 968-93-4 |
---|
SMILES | [H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H] |
---|
InChI Identifier | InChI=1S/C19H24O3/c1-18-9-7-13(20)11-12(18)3-4-14-15(18)8-10-19(2)16(14)5-6-17(21)22-19/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15+,16+,18+,19+/m1/s1 |
---|
InChI Key | BPEWUONYVDABNZ-DZBHQSCQSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as naphthopyrans. Naphthopyrans are compounds containing a pyran ring fused to a naphthalene moiety. Furan is a 6 membered-ring non-aromatic ring with five carbon and one oxygen atoms. Naphthalene is a polycyclic aromatic hydrocarbon made up of two fused benzene rings. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Naphthopyrans |
---|
Sub Class | Not Available |
---|
Direct Parent | Naphthopyrans |
---|
Alternative Parents | |
---|
Substituents | - Naphthopyran
- Naphthalene
- Delta valerolactone
- Delta_valerolactone
- Pyran
- Oxane
- Cyclic ketone
- Lactone
- Ketone
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Oxacycle
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 218.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.023 g/L | Not Available | LogP | 3.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|